2m 2m 2m 2m 2m 2m 2m
Optimus Hlthc (OHCS)
OTC
$0.0005$0.00 (0.00%)
Price as of Jun 26, 2026- $25,009.00Market Cap
- -98.70%1-Year Change
- Health Information ServicesIndustry
Optimus Hlthc (OHCS)
$0.0005$0.00 (0.00%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 1.5M +22.88% | 1.2M N/A | |
Cost of Revenue | 284,420 +8.27% | 262,689 N/A | |
Gross Profit | 1.2M +26.89% | 956,193 N/A | |
Sales and Marketing Expense | 11,288 -77.90% | 51,088 N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 17,235 -95.07% | 349,851 N/A | |
Total Operating Expenses | 9.8M +8.47% | 9.0M N/A | |
Operating Profit | -8.6M +6.28% | -8.1M N/A | |
Interest Income | 16,200 +2,214.29% | 700 N/A | |
Interest Expense | -614,024 +89.29% | -324,385 N/A | |
Interest Income and Expense and Net | -597,824 +84.69% | -323,685 N/A | |
Total Nonoperating Income and Expense | -2.5M +27.40% | -2.0M N/A | |
Income before Taxes | -11.1M +10.45% | -10.1M N/A | |
Income Taxes | 2,033 -99.70% | 674,292 N/A | |
Extraordinary Items | N/A N/A | 0 N/A | |
Net Income | -11.1M +3.53% | -10.7M N/A | |
Net Income from Continuing Operations Applicable to Common | -11.1M +10.45% | -10.1M N/A | |
Basic EPS and Net Income | N/A N/A | -0.28 N/A | |
Diluted EPS and Net Income | N/A N/A | -0.28 N/A | |
Basic Weighted Average Shares | 40.0M +3.05% | 38.8M N/A | |
Diluted Weighted Average Shares | 40.0M +3.05% | 38.8M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 100,319 -86.64% | 751,017 N/A | |
Short-Term Investments | N/A N/A | 144,199 N/A | |
Cash and Cash Equivalents and Short-Term Investments | 100,319 -88.79% | 895,216 N/A | |
Total Current Assets | 806,618 -53.26% | 1.7M N/A | |
Accumulated Depreciation | 24,500 +0.43% | 24,396 N/A | |
Property and Plant and Equipment and Net | 39,164 -30.31% | 56,196 N/A | |
Total Long-Term Assets | 39,164 -30.31% | 56,196 N/A | |
Total Assets | 1.1M -63.60% | 2.9M N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 5.8M +3,853.58% | 145,981 N/A | |
Total Current Liabilities | 8.0M +424.14% | 1.5M N/A | |
Total Long-Term Debt | 0 -100.00% | 2.8M N/A | |
Total Long-Term Liabilities | 175,344 -38.06% | 283,092 N/A | |
Total Liabilities | 8.2M +79.19% | 4.6M N/A | |
Retained Earnings | -30.1M +58.33% | -19.0M N/A | |
Total Stockholders Equity | -7.1M +334.88% | -1.6M N/A | |
Total Shares Outstanding | 40.0M +4.39% | 38.3M N/A | |
Cash Flow | |||
Cash from Operating Activities | -3.7M -8.69% | -4.0M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | 187,278 -71.25% | 651,460 N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.8M -26.51% | 3.9M N/A | |
Financials Ratio | |||
Gross Margin | 81.01% N/A | N/A N/A | |
Operating Margin | -572.37% N/A | N/A N/A | |
Return on Assets | -553.79% N/A | N/A N/A | |
Return on Equity | 252.96% N/A | N/A N/A | |
Revenue Growth | 22.88% N/A | N/A N/A | |
Current Ratio | 0.10 N/A | N/A N/A | |
Cash Ratio | 0.01 N/A | N/A N/A | |
Debt-to-Equity Ratio | -0.81 N/A | N/A N/A | |
Debt-to-Assets Ratio | 5.39 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow